JP2012503985A5 - - Google Patents

Download PDF

Info

Publication number
JP2012503985A5
JP2012503985A5 JP2011529281A JP2011529281A JP2012503985A5 JP 2012503985 A5 JP2012503985 A5 JP 2012503985A5 JP 2011529281 A JP2011529281 A JP 2011529281A JP 2011529281 A JP2011529281 A JP 2011529281A JP 2012503985 A5 JP2012503985 A5 JP 2012503985A5
Authority
JP
Japan
Prior art keywords
loci
subject
lupus
variation
prognosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011529281A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012503985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/058478 external-priority patent/WO2010036960A2/fr
Publication of JP2012503985A publication Critical patent/JP2012503985A/ja
Publication of JP2012503985A5 publication Critical patent/JP2012503985A5/ja
Pending legal-status Critical Current

Links

JP2011529281A 2008-09-26 2009-09-25 ループスの治療、診断、モニタリング方法 Pending JP2012503985A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10065908P 2008-09-26 2008-09-26
US61/100,659 2008-09-26
PCT/US2009/058478 WO2010036960A2 (fr) 2008-09-26 2009-09-25 Procédés pour traiter, diagnostiquer, et surveiller le lupus

Publications (2)

Publication Number Publication Date
JP2012503985A JP2012503985A (ja) 2012-02-16
JP2012503985A5 true JP2012503985A5 (fr) 2012-11-15

Family

ID=42060417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011529281A Pending JP2012503985A (ja) 2008-09-26 2009-09-25 ループスの治療、診断、モニタリング方法

Country Status (11)

Country Link
US (1) US20100099101A1 (fr)
EP (1) EP2344674A4 (fr)
JP (1) JP2012503985A (fr)
KR (1) KR20110081161A (fr)
CN (1) CN102224258A (fr)
AU (1) AU2009296393A1 (fr)
BR (1) BRPI0913778A2 (fr)
CA (1) CA2736373A1 (fr)
IL (1) IL211462A0 (fr)
MX (1) MX2011003273A (fr)
WO (1) WO2010036960A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008254582A1 (en) * 2007-05-21 2008-11-27 Genentech, Inc. Methods and compositions for identifying and treating lupus
EP2486152B1 (fr) 2009-10-07 2017-12-06 F. Hoffmann-La Roche AG Procédés pour diagnostiquer le lupus
CA3091939A1 (fr) 2009-11-02 2011-05-05 University Of Washington Compositions therapeutiques a base de nucleases et methodes
CN102465170A (zh) * 2010-11-05 2012-05-23 复旦大学附属华山医院 一种检测bank1基因单核苷酸多态性的方法
BR112013020498A2 (pt) * 2011-02-10 2016-08-09 Genqual Corp método para determinar a capacidade de resposta a inibidores e para tratamento de um sujeito
CA2834626A1 (fr) 2011-04-29 2012-11-01 University Of Washington Compositions a base de nuclease therapeutique et procedes associes
CN102360016A (zh) * 2011-07-21 2012-02-22 南京工业大学 流式微球法对SLE的Sm-RNP抗体检测试剂盒的制备
MX2015004145A (es) * 2012-10-08 2015-07-06 Hoffmann La Roche Peptidos de penetracion celular que se unen a factor regulador de interferon 5.
KR101491214B1 (ko) * 2012-10-10 2015-02-06 가톨릭대학교 산학협력단 1q25.1(RABGAP1L) 위치, 6p21.32 (C4) 위치 및 10q21.3위치의 DNA 복제 수 변이 검출용 프라이머를 포함하는 전신성 홍반성 루푸스 발병 위험도 예측용 조성물
WO2014058254A1 (fr) * 2012-10-10 2014-04-17 가톨릭대학교 산학협력단 Composition pour estimer le risque d'apparition d'un lupus érythémateux systémique, comprenant une amorce pour la détection de la variation du nombre de copies d'adn dans l'emplacement 1q25.1 (rabgap1l), l'emplacement 6p21.32 (c4) et l'emplacement 10.q21.3
EP2954071B1 (fr) * 2013-02-08 2020-08-12 Allegheny-Singer Research Institute Produits d'activation de complément liés à une cellule utilisés comme biomarqueurs diagnostiques pour le pré-lupus
US20140278133A1 (en) * 2013-03-15 2014-09-18 Advanced Throughput, Inc. Systems and methods for disease associated human genomic variant analysis and reporting
CN103397103B (zh) * 2013-08-26 2016-04-20 中国人民解放军第三军医大学第三附属医院 一种检测socs家族基因标签单核甘酸多态性位点的方法及试剂盒
ES2759252T3 (es) 2013-10-31 2020-05-08 Resolve Therapeutics Llc Fusiones y métodos terapéuticos de nucleasa-albúmina
EP2886140A1 (fr) 2013-12-17 2015-06-24 University of Limerick Appareil pour le traitement extracorporel du sang
US20170269075A1 (en) * 2014-05-12 2017-09-21 Biogen Ma Inc. Biomarkers predictive of lupus progression and uses thereof
AU2017290389B2 (en) 2016-07-01 2024-09-26 Resolve Therapeutics, Llc Optimized binuclease fusions and methods
AU2018321359B2 (en) 2017-08-22 2023-11-30 Sanabio, Llc Soluble interferon receptors and uses thereof
KR20240089752A (ko) * 2021-10-18 2024-06-20 카스턴 매뉴팩츄어링 코오포레이숀 골프 클럽 센서 하우징

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022476B2 (en) * 2002-02-26 2006-04-04 New York Society For Ruptured And Crippled Maintaining The Hospital For Special Surgery Human FcγRIIB gene polymorphisms for assessing development of systemic lupus erythematosus and compositions for use thereof
US20070269827A1 (en) * 2006-05-18 2007-11-22 Oklahoma Medical Research Foundation Predicting and Diagnosing Patients With Autoimmune Disease
AU2008254582A1 (en) * 2007-05-21 2008-11-27 Genentech, Inc. Methods and compositions for identifying and treating lupus
US20110319288A1 (en) * 2009-03-03 2011-12-29 Merck Serono S.A. Bank1 related snps and sle and/or ms susceptibility

Similar Documents

Publication Publication Date Title
JP2012503985A5 (fr)
JP2014533949A5 (fr)
JP2010528590A5 (fr)
CN107475371B (zh) 发现药物基因组生物标志物的方法
JP2009509508A5 (fr)
JP2010508042A5 (fr)
JP2018038436A5 (fr)
JP2010075182A5 (fr)
JP2011520433A5 (fr)
JP2011528903A5 (fr)
JP2011530312A5 (fr)
RU2018122965A (ru) Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания
JP2013544536A5 (fr)
Kim et al. Gene-based copy number variation study reveals a microdeletion at 12q24 that influences height in the Korean population
EP3314026A1 (fr) Polymorphisme mononucléotidique danshla-b*15:02
JP2013507127A5 (fr)
TW201345919A (zh) 探針、微陣列、探針群組、β地中海型貧血檢測套組、β血球蛋白基因變異檢測用套組、多態性檢測用微陣列探針對的評價方法以及基因型判別顯示程式
RU2016131167A (ru) Способы лечения, диагностики и мониторинга волчанки
WO2011020906A3 (fr) Analyse du polymorphisme spla2 iia pour le diagnostic/pronostic d'une maladie/d'un évènement cardiovasculaire
WO2011088306A1 (fr) Procédés d'utilisation de variants génétiques pour diagnostiquer la maladie de crohn
EP2689034B1 (fr) Rôle de la méthylation de l'interféron gamma dans la maladie intestinale inflammatoire
JP2006521812A5 (fr)
EP3315613B1 (fr) Procédés et kits pour diagnostiquer ou évaluer le risque de cancer du col de l'utérus
JP2016512950A (ja) 抗精神病薬に基づく処置により誘導される錐体外路症状(eps)の発症を予測する方法
Savarese et al. Enhancer chip: detecting human copy number variations in regulatory elements